NASDAQ: MYGNMyriad Genetics Inc Stock Ownership - Who owns Myriad Genetics?
Insider buying vs selling
Have Myriad Genetics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Samraat S. Raha | President and CEO | 2025-05-31 | 1,498 | $3.56 | $5.34kBuy |
| Mark Verratti | Chief Commercial Officer | 2025-04-14 | 1,085 | $8.08 | $8.77kSell |
| Dale Muzzey | Chief Scientific Officer | 2025-04-14 | 942 | $8.08 | $7.61kSell |
| Natalie Munk | Chief Accounting Officer | 2025-03-25 | 362 | $9.73 | $3.52kSell |
| Kevin Richard Haas | Chief Technology Officer | 2025-03-24 | 1,724 | $9.98 | $17.21kSell |
| Kevin Richard Haas | Chief Technology Officer | 2025-03-24 | 1,177 | $9.98 | $11.75kSell |
| Dale Muzzey | Chief Scientific Officer | 2025-03-24 | 800 | $9.98 | $7.98kSell |
| Mark Verratti | Chief Commercial Officer | 2025-03-24 | 1,605 | $9.98 | $16.02kSell |
| Mark Verratti | Chief Commercial Officer | 2025-03-24 | 1,096 | $9.98 | $10.94kSell |
| Dale Muzzey | Chief Scientific Officer | 2025-03-24 | 545 | $9.98 | $5.44kSell |
MYGN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when MYGN insiders and whales buy or sell their stock.
MYGN Shareholders
What type of owners hold Myriad Genetics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Blackrock Inc | 16.77% | 15,458,176 | $77.75M | Institution |
| Vanguard Group Inc | 11.57% | 10,667,755 | $53.66M | Institution |
| State Street Corp | 5.72% | 5,268,790 | $26.50M | Institution |
| Disciplined Growth Investors Inc | 5.14% | 4,733,692 | $23.81M | Institution |
| Wellington Management Group LLP | 4.98% | 4,592,264 | $23.10M | Institution |
| Millennium Management LLC | 4.41% | 4,069,526 | $20.47M | Institution |
| Earnest Partners LLC | 4.31% | 3,977,292 | $20.01M | Institution |
| Glenview Capital Management LLC | 4.23% | 3,899,550 | $19.61M | Institution |
| Bank Of America Corp | 2.85% | 2,631,156 | $13.23M | Institution |
| D E Shaw Co Inc | 2.74% | 2,522,618 | $12.69M | Institution |
MYGN vs Diagnostic & Research Stocks
Myriad Genetics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.